Overcoming NS1-Mediated immune antagonism involves both interferon-dependent and independent mechanisms

Journal of Interferon and Cytokine Research

Volumn 33, Issue 11, 2013, Pages 700-708

  Thakar, Juilee ^a   Schmid, Sonja ^b   Duke, Jamie L ^c   García Sastre, Adolfo ^b   Kleinstein, Steven H ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CCAAT ENHANCER BINDING PROTEIN; CXCL16 CHEMOKINE; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 13; INTERLEUKIN 23; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; NONSTRUCTURAL PROTEIN 1; STAT1 PROTEIN; STAT3 PROTEIN; STAT5A PROTEIN; STROMAL CELL DERIVED FACTOR 1; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; ALPHA BETA INTERFERON RECEPTOR; CYTOKINE RECEPTOR; IFNAR1 PROTEIN, MOUSE; INS1 PROTEIN, INFLUENZA VIRUS; INTERLEUKIN 28ALPHA RECEPTOR; VIRUS PROTEIN;

ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE ACTIVATION; BINDING SITE; BIOINFORMATICS; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; GENE INDUCTION; GENETIC ANALYSIS; IMMUNE EVASION; INFLUENZA A; LEUKOCYTE MIGRATION; LUNG PARENCHYMA; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; UPREGULATION; VIRAL CLEARANCE; VIRUS RESISTANCE; VIRUS STRAIN; WILD TYPE; ANIMAL; C57BL MOUSE; DEFICIENCY; GENETICS; IMMUNOLOGY; INFLUENZA VIRUS A; KNOCKOUT MOUSE; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; IMMUNE EVASION; INFLUENZA A VIRUS; INTERFERONS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84887085664     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0113     Document Type: Article

References (49)

1. Akira S, Takeda K, et al. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2(8):675-680.
2. Beer MA, Tavazoie S. 2004. Predicting gene expression from sequence. Cell 117(2):185-198.
3. Bengal E, Ransone L, et al. 1992. Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell 68(3):507-519.
4. Blanchette M, Kent WJ, et al. 2004. Aligning multiple genomic sequences with the threaded blockset aligner. Genome Res 14(4):708-715.
5. Bruford EA, Lush MJ, et al. 2008. The HGNC Database in 2008: a resource for the human genome. Nucleic Acids Res 36(Database issue): D445-D448.
6. Chua MA, Schmid S, et al. 2013. Influenza a virus utilizes suboptimal splicing to coordinate the timing of infection. Cell Rep 3(1):23-29.
7. Dumoutier L, Tounsi A, et al. 2004. Role of the interleukin (IL)- 28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. J Biol Chem 279(31):32269-32274.
8. Falcon S, Gentleman R. 2007. Using GOstats to test gene lists for GO term association. Bioinformatics 23(2):257-258.
9. Geiss GK, Salvatore M, et al. 2002. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci U S A 99(16):10736-10741.
10. Gentleman RC, Carey VJ, et al. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5(10):R80.
11. Grimm D, Staeheli P, et al. 2007. Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc Natl Acad Sci U S A 104(16):6806-6811.
12. Hale BG, Randall RE, et al. 2008. The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89(Pt 10):2359-2376.
13. Haye K, Burmakina S, et al. 2009. The NS1 protein of a human influenza virus inhibits type I interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells. J Virol 83(13):6849-6862.
14. Hayman A, Comely S, et al. 2007. NS1 proteins of avian influenza A viruses can act as antagonists of the human alpha/ beta interferon response. J Virol 81(5):2318-2327.
15. Honda K, Takaoka A, et al. 2006. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25(3):349-360.
16. Horisberger MA, Staeheli P, et al. 1983. Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc Natl Acad Sci U S A 80(7):1910-1914.
17. Hu J, Sealfon SC, et al. 2007. Chromosome-specific and noisy IFNB1 transcription in individual virus-infected human primary dendritic cells. Nucleic Acids Res 35(15):5232-5241.
18. Idzko M, Hammad H, et al. 2007. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 13(8):913-919.
19. Kel AE, Gossling E, et al. 2003. MATCH: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res 31(13):3576-3579.
20. Kochs G, Koerner I, et al. 2007. Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. J Gen Virol 88(Pt 5):1403-1409.
21. Koudritsky M, Domany E. 2008. Positional distribution of human transcription factor binding sites. Nucleic Acids Res 36(21):6795-6805.
22. Kumagai Y, Takeuchi O, et al. 2007. Alveolar macrophages are the primary interferon-Alpha producer in pulmonary infection with RNA viruses. Immunity 27(2):240-252.
23. Lin R, Genin P, et al. 2000. Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol Cell Biol 20(17):6342-6353.
24. Martinon F, Petrilli V, et al. 2006. Gout-Associated uric acid crystals activate the NALP3 inflammasome. Nature 440(7081):237-241.
25. Matys V, Fricke E, et al. 2003. TRANSFAC: transcriptional regulation, frompatterns to profiles.Nucleic Acids Res 31(1):374-378.
26. Moltedo B, Lopez CB, et al. 2009. Cutting edge: stealth influenza virus replication precedes the initiation of adaptive immunity. J Immunol 183(6):3569-3573.
27. Mordstein M, Kochs G, et al. 2008. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog 4(9):e1000151.
28. Ning S, Pagano JS, et al. 2011. IRF7: activation, regulation, modification and function. Genes Immun 12(6):399-414.
29. Panne D, Maniatis T, et al. 2004. Crystal structure of ATF-2/c- Jun and IRF-3 bound to the interferon-beta enhancer. EMBO J 23(22):4384-4393.
30. Potthoff MJ, Olson EN. 2007. MEF2: a central regulator of diverse developmental programs. Development 134(23):4131-4140.
31. Presanis AM, Pebody RG, et al. 2011. Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis. BMJ 343:d5408.
32. Pruitt KD, Tatusova T, et al. 2005. NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 33(Database issue):D501-D504.
33. Randall RE, Goodbourn S. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89(Pt 1):1-47.
34. Roach JC, Smith KD, et al. 2007. Transcription factor expression in lipopolysaccharide-Activated peripheral-blood-derived mononuclear cells. Proc Natl Acad Sci U S A 104(41):16245-16250.
35. Schmid S, Mordstein M, et al. 2011. Transcription factor redundancy ensures induction of the antiviral state. J Biol Chem 285(53):42013-42022.
36. Schnare M, Barton GM, et al. 2001. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2(10):947-950.
37. Schoggins JW, Wilson SJ, et al. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472(7344):481-485.
38. Simonsen L, Clarke MJ, et al. 1997. The impact of influenza epidemics on mortality: introducing a severity index. AmJ Public Health 87(12):1944-1950.
39. Talon J, Horvath CM, et al. 2000. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74(17):7989-7996.
40. Taubenberger JK, Reid AH, et al. 2000. The 1918 influenza virus: a killer comes into view. Virology 274(2):241-245.
41. Thompson MG, Shay DK, et al. 2010. Estimates of deaths associated with seasonal influenza-United States, 1976-2007.MMWR Morb Mortal Wkly Rep 59(33):1057-1062.
42. Tisoncik JR, Billharz R, et al. 2011. The NS1 protein of influenza A virus suppresses interferon-regulated activation of antigen presentation and immune-proteasome pathways. J Gen Virol 92(Pt9):2093-2104.
43. Waddell SJ, Popper SJ, et al. 2010. Dissecting interferon-induced transcriptional programs in human peripheral blood cells. PLoS One 5(3):e9753.
44. Wang IM, Contursi C, et al. 2000a. An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages. J Immunol 165(1):271-279.
45. Wang X, Li M, et al. 2000b. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol 74(24):11566-11573.
46. Webster RG. 1999. 1918 Spanish influenza: the secrets remain elusive. Proc Natl Acad Sci U S A 96(4):1164-1166.
47. Wise HM, Foeglein A, et al. 2009. A complicated message: identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol 83(16):8021-8031.
48. Wolff T, Ludwig S. 2009. Influenza viruses control the vertebrate type I interferon system: factors, mechanisms, and consequences. J Interferon Cytokine Res 29(9):549-557.
49. Zaslavsky E, Hershberg U, et al. 2010. Antiviral response dictated by choreographed cascade of transcription factors. J Immunol 184(6):2908-2917.